Recurrent Copy Number Variants and Psychiatric Outcomes in the Context of Polygenic Scores.
Vaez M +14 more
europepmc +1 more source
Association Between Task Difficulty Regulation in Game-Based Digital Therapeutics and Attention-Deficit/Hyperactivity Disorder Symptoms in Children: Secondary Analysis of a Randomized Controlled Trial. [PDF]
Kim JS +11 more
europepmc +1 more source
Prevalence and age of diagnosis of neurodevelopmental conditions among Asian populations in Aotearoa New Zealand. [PDF]
Panther NK +6 more
europepmc +1 more source
ADHD medication discontinuation and non-adherence: a Norwegian population-based register study. [PDF]
Garcia-Argibay M +4 more
europepmc +1 more source
Correction: An Open‑Label Extension Study Assessing the Long‑Term Safety and Efficacy of Viloxazine Extended‑Release Capsules in Adults with Attention‑Deficit/Hyperactivity Disorder. [PDF]
Childress A +7 more
europepmc +1 more source
Mood instability and mental health service use in autism and attention-deficit/hyperactivity disorder: a natural language processing analysis of CRIS electronic healthcare records from 21 906 children and adolescents. [PDF]
Seker A +6 more
europepmc +1 more source
The SIRT-1/Nrf-2/HO-1 antioxidant defense axis in adult attention-deficit/hyperactivity disorder. [PDF]
Gürbüzer N, Ozkaya A, Mercantepe F.
europepmc +1 more source
Stigmatising Attitudes Towards People With Depression, Bipolar Disorder, Borderline Personality, ADHD and Early and Long-Term/Untreated Schizophrenia: Representative Survey of Australian Adults. [PDF]
Morgan AJ +4 more
europepmc +1 more source
The effect of phosphatidylserine on behavioral problems in children with attention deficit hyperactivity disorder. [PDF]
Shen Z +5 more
europepmc +1 more source
Trends in antipsychotic drug utilisation and indication in the paediatric population: a nationwide cohort study in Sweden. [PDF]
S Kamgang KH +4 more
europepmc +1 more source

